Yayın: Design, synthesis and biological evaluation of new bis(thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer
| dc.contributor.author | SEVER, BELGİN | |
| dc.contributor.author | AKALIN ÇİFTÇİ, GÜLŞEN | |
| dc.contributor.author | ALTINTOP, MEHLİKA DİLEK | |
| dc.contributor.author | Mehlika Dilek Altıntop | |
| dc.contributor.orcid | 0000-0003-4847-9711 | |
| dc.contributor.orcid | 0000-0001-9535-2508 | |
| dc.contributor.orcid | 0000-0003-0280-5550 | |
| dc.contributor.orcid | 0000-0002-8159-663X | |
| dc.date.accessioned | 2025-11-13T12:18:11Z | |
| dc.date.issued | 2020-09-11 | |
| dc.identifier.doi | https://doi.org/10.35333/jrp.2020.222 | |
| dc.identifier.endpage | 680 | |
| dc.identifier.issn | 2630-6344 | |
| dc.identifier.issue | 5 | |
| dc.identifier.openalex | W3086530529 | |
| dc.identifier.startpage | 670 | |
| dc.identifier.uri | https://hdl.handle.net/11421/9605 | |
| dc.identifier.uri | https://doi.org/10.35333/jrp.2020.222 | |
| dc.identifier.volume | 24 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Research in Pharmacy | |
| dc.rights | openAccess | |
| dc.subject | Semicarbazone | |
| dc.subject | Cancer | |
| dc.subject | Cell | |
| dc.subject | Cancer research | |
| dc.subject | Combinatorial chemistry | |
| dc.subject | Chemistry | |
| dc.subject | Pharmacology | |
| dc.subject | Nanotechnology | |
| dc.subject | Medicine | |
| dc.subject | Internal medicine | |
| dc.subject | Stereochemistry | |
| dc.subject | Materials science | |
| dc.subject | Biochemistry | |
| dc.subject.sdg | 3 | |
| dc.title | Design, synthesis and biological evaluation of new bis(thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5040352588 | |
| local.authorid.openalex | A5059753642 | |
| local.authorid.openalex | A5048968214 |
